NovoCure Ltd (NVCR) shareholders
Close on Nov 17, 2026Market cap $1.30BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Abigail P. Johnson Joint filing with FMR LLC (14.94%) | 15,962,765 | 14.94% | 13G (passive) amendment | Feb 9, 2024 |
| Soleus Capital, LLC Joint filing with Soleus Capital Master Fund, L.P. (9.10%), Soleus Capital Group, LLC (9.10%) and 3 more | 10,492,391 | 9.10% | 13G (passive) amendment | Mar 31, 2026 |
| Soleus Capital Management, L.P. Joint filing with Soleus Capital Master Fund, L.P. (8.10%), Soleus Capital, LLC (8.10%) and 3 more | 9,425,776 | 8.10% | 13G (passive) amendment | Sep 30, 2026 |
| BlackRock, Inc. | 9,083,620 | 8.30% | 13G (passive) amendment | Mar 31, 2025 |
| Soleus Capital Group, LLC Joint filing with Soleus Capital Master Fund, L.P. (7.60%), Soleus Capital, LLC (7.60%) and 3 more | 8,530,665 | 7.60% | 13G (passive) amendment | Dec 31, 2025 |
| Soleus GP, LLC Joint filing with Soleus Capital Master Fund, L.P. (6.20%), Soleus Capital, LLC (6.20%) and 3 more | 6,904,302 | 6.20% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Portfolio Management | 6,339,994 | 5.57% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NVCR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 17,373,078 | 14.86% | $263.20M | +303,929 | 0.01% |
| BlackRock, Inc. | 13,413,699 | 11.47% | $203.22M | +219,934 | 0.00% |
| Soleus Capital Management, L.P. | 9,913,401 | 8.48% | $150.19M | −578,990 | 5.18% |
| Vanguard Portfolio Management LLC | 6,272,490 | 5.36% | $95.03M | +20,789 | 0.00% |
| Vanguard Capital Management LLC | 4,903,633 | 4.19% | $74.29M | +221,569 | 0.00% |
| Morgan Stanley | 4,522,389 | 3.87% | $68.51M | −19,137 | 0.00% |
| State Street Corp | 2,866,546 | 2.45% | $43.43M | +304,729 | 0.00% |
| Geode Capital Management, LLC | 2,798,351 | 2.39% | $42.40M | +286,644 | 0.00% |
| Wells Fargo & Company/Mn | 2,528,093 | 2.16% | $38.30M | −423,144 | 0.01% |
| Quantinno Capital Management LP | 2,223,455 | 1.90% | $33.69M | −263,921 | 0.04% |
| Renaissance Technologies LLC | 1,951,911 | 1.67% | $29.57M | +400,357 | 0.04% |
| JPMorgan Chase & Co | 1,671,082 | 1.43% | $25.94M | +740,916 | 0.00% |
| Healthcare Of Ontario Pension Plan Trust Fund | 1,385,600 | 1.19% | $20.99M | +659,200 | 0.03% |
| Palo Alto Investors LP | 1,280,439 | 1.10% | $19.40M | – | 2.68% |
| Nuveen, LLC | 1,232,087 | 1.05% | $18.67M | +249,734 | 0.00% |
| Jacobs Levy Equity Management, Inc | 1,164,072 | 1.00% | $17.64M | −167,420 | 0.06% |
| Empowered Funds, LLC | 1,154,431 | 0.99% | $17.49M | New | 0.09% |
| Aqr Capital Management LLC | 1,102,131 | 0.94% | $16.65M | +827,199 | 0.01% |
| Dimensional Fund Advisors LP | 1,091,946 | 0.93% | $16.55M | +131,890 | 0.00% |
| D. E. Shaw & Co., Inc. | 1,022,480 | 0.87% | $15.49M | +375,418 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 216 | 103M | 88.5% | 32 / 90 | 63 / 35 | 12M | 7M |
| Q1 2026 | 224 | 99M | 84.6% | 39 / 76 | 75 / 50 | 23M | 9M |
| Q4 2025 | 239 | 96M | 81.8% | 44 / 100 | 61 / 40 | 16M | 11M |
| Q3 2025 | 245 | 92M | 78.7% | 48 / 84 | 80 / 45 | 13M | 15M |
| Q2 2025 | 243 | 94M | 80.8% | 46 / 86 | 70 / 29 | 13M | 14M |
| Q1 2025 | 228 | 95M | 81.4% | 39 / 71 | 77 / 48 | 12M | 8M |
| Q4 2024 | 239 | 92M | 78.4% | 54 / 66 | 77 / 37 | 10M | 12M |
| Q3 2024 | 225 | 93M | 79.8% | 25 / 61 | 80 / 33 | 23M | 11M |
| Q2 2024 | 237 | 93M | 79.6% | 47 / 77 | 70 / 45 | 15M | 14M |
| Q1 2024 | 238 | 93M | 79.4% | 44 / 81 | 63 / 25 | 11M | 10M |
| Q4 2023 | 220 | 92M | 78.8% | 45 / 84 | 55 / 50 | 15M | 15M |
| Q3 2023 | 227 | 92M | 78.8% | 43 / 73 | 64 / 82 | 13M | 11M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| William F. Doyle | Executive Chairman, Director | 681,167 | 0.58% | Mar 5, 2026 |
| Mukund Paravasthu | Chief Operating Officer | 69,753 | 0.06% | Nov 12, 2026 |
| Christoph Brackmann | Chief Financial Officer | 175,499 | 0.15% | Nov 12, 2026 |
| Michal Nath Puri | Chief Human Resources Officer | 202,567 | 0.17% | Nov 4, 2026 |
| Arye Barak Ben | General Counsel | 243,752 | 0.21% | Jul 1, 2026 |
| Frank X. Leonard | Chief Executive Officer | 461,425 | 0.39% | Jul 1, 2026 |
| Nicolas Leupin | Former Chief Medical Officer | 102,979 | 0.09% | Mar 5, 2026 |
| Uri Weinberg | Chf Medical and Innovation Ofr | 267,190 | 0.23% | Mar 5, 2026 |
| Ashley Cordova | Former Chief Executive Officer | 422,570 | 0.36% | Mar 5, 2026 |
| Asaf Danziger | Director | 416,742 | 0.36% | Jul 1, 2026 |
| Martin J. Madden | Director | 30,668 | 0.03% | Jun 5, 2026 |
| Timothy J. Scannell | Director | 25,898 | 0.02% | Jun 5, 2026 |
| W. Anthony Vernon | Director | 209,267 | 0.18% | Jun 5, 2026 |
| Gabriel Leung | Director | 101,109 | 0.09% | Jun 5, 2026 |
| Jeryl L. Hilleman | Director | 25,471 | 0.02% | Jun 5, 2026 |
| David Hung | Director | 32,075 | 0.03% | Jun 5, 2026 |
| Kristin Stafford | Director | 22,934 | 0.02% | Jun 5, 2026 |
| Allyson J. Ocean | Director | 22,934 | 0.02% | Jun 5, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Christoph Brackmann Chief Financial Officer | Nov 9, 2026 | Sale | −7,343 | $12.86 | $94.45K | 175,499 |
| Mukund Paravasthu Chief Operating Officer | Nov 9, 2026 | Sale | −3,079 | $12.86 | $39.60K | 69,753 |
| Michal Nath Puri Chief Human Resources Officer | Nov 2, 2026 | Sale | −660 | $13.24 | $8.74K | 202,567 |
| Asaf Danziger Director | Jun 30, 2026 | Award | +268 | $11.15 | $2.99K | 416,742 |
| Arye Barak Ben General Counsel | Jun 30, 2026 | Award | +1,299 | $11.15 | $14.48K | 243,752 |
| Michal Nath Puri Chief Human Resources Officer | Jun 30, 2026 | Award | +1,905 | $11.15 | $21.24K | 203,227 |
| Frank X. Leonard Chief Executive Officer | Jun 30, 2026 | Award | +1,905 | $11.15 | $21.24K | 461,425 |
| Frank X. Leonard Chief Executive Officer | Jun 4, 2026 | Sale | −34,273 | $17.93 | $614.51K | 459,520 |
| W. Anthony Vernon Director | Jun 3, 2026 | Award | +11,610 | – | – | 209,267 |
| Kristin Stafford Director | Jun 3, 2026 | Award | +11,610 | – | – | 22,934 |
| David Hung Director | Jun 3, 2026 | Award | +11,610 | – | – | 32,075 |
| Allyson J. Ocean Director | Jun 3, 2026 | Award | +11,610 | – | – | 22,934 |
| Martin J. Madden Director | Jun 3, 2026 | Award | +11,610 | – | – | 30,284 |
| Timothy J. Scannell Director | Jun 3, 2026 | Award | +11,610 | – | – | 25,898 |
| Jeryl L. Hilleman Director | Jun 3, 2026 | Award | +11,610 | – | – | 25,471 |
| Gabriel Leung Director | Jun 3, 2026 | Award | +11,610 | – | – | 101,109 |
| Allyson J. Ocean Director | Jun 2, 2026 | Sale | −2,945 | $15.77 | $46.44K | 11,324 |
| W. Anthony Vernon Director | Jun 2, 2026 | Sale | −2,945 | $15.77 | $46.44K | 197,657 |
| Kristin Stafford Director | Jun 2, 2026 | Sale | −2,945 | $15.77 | $46.44K | 11,324 |
| David Hung Director | Jun 2, 2026 | Sale | −2,945 | $15.77 | $46.44K | 20,465 |
| Gabriel Leung Director | Jun 2, 2026 | Sale | −2,945 | $15.77 | $46.44K | 89,499 |
| Timothy J. Scannell Director | Jun 2, 2026 | Sale | −2,945 | $15.77 | $46.44K | 14,288 |
| Jeryl L. Hilleman Director | Jun 2, 2026 | Sale | −2,945 | $15.77 | $46.44K | 13,861 |
| W. Anthony Vernon Director | Apr 28, 2026 | Option exercise | +21,500 | $11.39 | $244.89K | 200,602 |
| Mukund Paravasthu Chief Operating Officer | Mar 5, 2026 | Sale | −43,246 | $13.77 | $595.50K | 72,832 |
| Frank X. Leonard Chief Executive Officer | Mar 4, 2026 | Sale | −5,607 | $13.31 | $74.63K | 493,793 |
| Mukund Paravasthu Chief Operating Officer | Mar 4, 2026 | Sale | −5,377 | $13.31 | $71.57K | 116,078 |
| Ashley Cordova Former Chief Executive Officer | Mar 4, 2026 | Tax withholding | −17,638 | $13.30 | $234.59K | 422,570 |
| Christoph Brackmann Chief Financial Officer | Mar 4, 2026 | Sale | −6,412 | $13.31 | $85.34K | 182,842 |
| Michal Nath Puri Chief Human Resources Officer | Mar 4, 2026 | Sale | −1,100 | $13.31 | $14.64K | 201,322 |
| Nicolas Leupin Former Chief Medical Officer | Mar 4, 2026 | Sale | −1,100 | $13.31 | $14.64K | 102,979 |
| Uri Weinberg Chf Medical and Innovation Ofr | Mar 4, 2026 | Sale | −6,412 | $13.31 | $85.34K | 267,190 |
| Arye Barak Ben General Counsel | Mar 3, 2026 | Award | +50,125 | – | – | 242,453 |
| Frank X. Leonard Chief Executive Officer | Mar 3, 2026 | Award | +150,000 | – | – | 499,400 |
| Mukund Paravasthu Chief Operating Officer | Mar 3, 2026 | Award | +45,112 | – | – | 121,455 |
| William F. Doyle Executive Chairman, Director | Mar 3, 2026 | Award | +200,000 | – | – | 200,000 |
| William F. Doyle Executive Chairman, Director | Mar 3, 2026 | Sale | −50,557 | $12.79 | $646.62K | 349,727 |
| William F. Doyle Executive Chairman, Director | Mar 3, 2026 | Sale | −21,330 | $13.43 | $286.46K | 328,397 |
| William F. Doyle Executive Chairman, Director | Mar 3, 2026 | Award | +200,284 | – | – | 400,284 |
| Christoph Brackmann Chief Financial Officer | Mar 3, 2026 | Award | +55,137 | – | – | 189,254 |
| Michal Nath Puri Chief Human Resources Officer | Mar 3, 2026 | Award | +40,100 | – | – | 202,422 |
| Uri Weinberg Chf Medical and Innovation Ofr | Mar 3, 2026 | Award | +50,125 | – | – | 273,602 |
| Uri Weinberg Chf Medical and Innovation Ofr | Mar 2, 2026 | Sale | −3,272 | $13.33 | $43.62K | 223,477 |
| Mukund Paravasthu Chief Operating Officer | Mar 2, 2026 | Sale | −408 | $13.49 | $5.50K | 76,343 |
| Ashley Cordova Former Chief Executive Officer | Mar 2, 2026 | Tax withholding | −7,228 | $13.67 | $98.81K | 440,208 |
| Ashley Cordova Former Chief Executive Officer | Mar 2, 2026 | Tax withholding | −2,410 | $13.67 | $32.94K | 447,436 |
| Frank X. Leonard Chief Executive Officer | Mar 2, 2026 | Sale | −7,232 | $13.49 | $97.56K | 349,400 |
| Uri Weinberg Chf Medical and Innovation Ofr | Feb 28, 2026 | Award | +12,992 | – | – | 226,749 |
| Ashley Cordova Former Chief Executive Officer | Feb 28, 2026 | Award | +23,818 | – | – | 449,846 |
| Frank X. Leonard Chief Executive Officer | Feb 28, 2026 | Award | +18,621 | – | – | 356,632 |
| Arye Barak Ben General Counsel | Feb 28, 2026 | Award | +17,755 | – | – | 192,328 |
| Uri Weinberg Chf Medical and Innovation Ofr | Feb 27, 2026 | Sale | −7,461 | $13.84 | $103.26K | 213,757 |
| Mukund Paravasthu Chief Operating Officer | Feb 27, 2026 | Sale | −1,555 | $13.66 | $21.24K | 76,751 |
| Ashley Cordova Former Chief Executive Officer | Feb 27, 2026 | Tax withholding | −11,541 | $13.75 | $158.69K | 426,028 |
| Nicolas Leupin Former Chief Medical Officer | Feb 27, 2026 | Sale | −1,029 | $13.66 | $14.06K | 104,079 |
| Frank X. Leonard Chief Executive Officer | Feb 27, 2026 | Sale | −9,734 | $13.66 | $132.97K | 338,011 |
| Michal Nath Puri Chief Human Resources Officer | Feb 27, 2026 | Sale | −1,441 | $13.66 | $19.68K | 162,322 |
| Mukund Paravasthu Chief Operating Officer | Jan 11, 2026 | Tax withholding | −2,133 | $14.35 | $30.61K | 78,306 |
| Arye Barak Ben General Counsel | Dec 31, 2025 | Award | +108 | $10.99 | $1.19K | 174,573 |
| Michal Nath Puri Chief Human Resources Officer | Dec 31, 2025 | Award | +1 | $10.99 | $11 | 163,763 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NovoCure's stock actually held short. Settlement fails (shares not delivered on time) peaked at 22,282 shares on Aug 27, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Christoph Brackmann Officer | Nov 9, 2026 | 7,343 | $94.45K | Nov 9, 2026 | Restricted Stock |
| Nicolas Leupin Officer | Jul 23, 2026 | 39,088 | $608.60K | Jul 23, 2026 | Exercise of Stock Options |
| Francis Leonard Officer | Jun 4, 2026 | 34,273 | $614.63K | Jun 4, 2026 | Restricted Stock |
| Mukund Paravasthu Officer | Mar 5, 2026 | 43,246 | $595.68K | Mar 5, 2026 | Restricted stock vesting under a registered plan |
| Christoph Brackmann Officer | Mar 4, 2026 | 6,412 | $85.31K | Mar 4, 2026 | Restricted stock |
| Uri Weinberg Officer | Mar 4, 2026 | 6,412 | $85.31K | Mar 4, 2026 | Restricted stock |
| Mukund Paravasthu Officer | Mar 4, 2026 | 5,377 | $71.54K | Mar 4, 2026 | Restricted Stock |
| Francis Leonard Officer | Mar 4, 2026 | 5,607 | $74.60K | Mar 4, 2026 | Restricted Stock |
| William F. Doyle Officer, Director | Mar 3, 2026 | 71,887 | $932.88K | Mar 3, 2026 | Performance Shares |
| Francis Leonard Officer | Mar 2, 2026 | 7,232 | $97.58K | Mar 2, 2026 | Performance Shares |
| Uri Weinberg Officer | Mar 2, 2026 | 3,272 | $43.61K | Mar 2, 2026 | Restricted Stock |
| Francis Leonard Officer | Feb 27, 2026 | 9,734 | $133.00K | Feb 27, 2026 | Restricted Stock |
| Uri Weinberg Officer | Feb 27, 2026 | 7,461 | $103.26K | Feb 27, 2026 | Restricted Stock |
| Francis Leonard Officer | Jun 2, 2025 | 30,196 | $577.05K | Jun 2, 2025 | Restricted Stock Units |
| Mukund Paravasthu Officer | May 5, 2025 | 592 | $10.60K | May 5, 2025 | Restricted Stock |
See a number that looks wrong?